Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Leroyer

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Revue Des Maladies Respiratoires|February 12, 2010
[Pulmonary arterial hypertension in the elderly subject]I Frachon, A Barnier, Y Jobic, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolismE Oger, C Leroyer, L Bressollette, et al.
Revue De Pneumologie Clinique|November 21, 2015
[Comorbidities of COPD]G Brinchault, P Diot, A Dixmier, et al.
Revue Des Maladies Respiratoires|October 16, 2018
[Risk factors for thromboembolic disease in young women-the role of hormones]C Tromeur, R Le Mao, P Jego, et al.
American Journal of Clinical Pathology|June 10, 1998
Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer)M Escoffre-Barbe, E Oger, C Leroyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 5, 1998
Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-RE Oger, C Leroyer, B Mercier, et al.
Haemostasis|March 24, 1999
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study GroupC Leroyer, L Bressollette, E Oger, et al.
Allergy|July 21, 2009
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmaticsM Humbert, F de Blay, G Garcia, et al.
Revue Des Maladies Respiratoires|October 24, 2006
[Characteristics of mild asthma: descriptive epidemiology and nature of bronchial inflammation. Position of the Mild Asthma Working Group]P Chanez, J de Blic, C Delacourt, et al.
Revue Des Maladies Respiratoires|January 5, 2007
[Characteristics of mild asthma: clinical signs and medication use. Position statement of the Mild Asthma Working Group (174)]P Chanez, J de Blic, C Delacourt, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Revue Des Maladies Respiratoires|February 12, 2010
[Pulmonary arterial hypertension in the elderly subject]I Frachon, A Barnier, Y Jobic, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolismE Oger, C Leroyer, L Bressollette, et al.
Revue De Pneumologie Clinique|November 21, 2015
[Comorbidities of COPD]G Brinchault, P Diot, A Dixmier, et al.
Revue Des Maladies Respiratoires|October 16, 2018
[Risk factors for thromboembolic disease in young women-the role of hormones]C Tromeur, R Le Mao, P Jego, et al.
American Journal of Clinical Pathology|June 10, 1998
Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer)M Escoffre-Barbe, E Oger, C Leroyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 5, 1998
Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-RE Oger, C Leroyer, B Mercier, et al.
Haemostasis|March 24, 1999
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study GroupC Leroyer, L Bressollette, E Oger, et al.
Allergy|July 21, 2009
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmaticsM Humbert, F de Blay, G Garcia, et al.
Revue Des Maladies Respiratoires|October 24, 2006
[Characteristics of mild asthma: descriptive epidemiology and nature of bronchial inflammation. Position of the Mild Asthma Working Group]P Chanez, J de Blic, C Delacourt, et al.
Revue Des Maladies Respiratoires|January 5, 2007
[Characteristics of mild asthma: clinical signs and medication use. Position statement of the Mild Asthma Working Group (174)]P Chanez, J de Blic, C Delacourt, et al.
Pageof 10